| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash | $365K-53.5% | $786K+37.8% | $570K-95.3% | $12.1M+448.1% | $2.2M |
| Accounts receivable, net | $1.7M+12.9% | $1.5M+20.0% | $1.2M-39.0% | $2.0M+31.9% | $1.5M |
| Inventory [Note 3] | $1.6M-17.2% | $1.9M-19.6% | $2.3M+177.2% | $843K+209.3% | $272K |
| Deposits and other receivables | $1.1M+215.0% | $336K-42.8% | $589K+44.9% | $406K+24.4% | $327K |
| Total current assets | $4.6M+3.8% | $4.5M-5.3% | $4.7M-69.2% | $15.3M+254.6% | $4.3M |
| Deposits and other receivables [Note 12] | $109K+28.6% | $85K+0.0% | $85K+0.0% | $85K | — |
| Long-term accounts receivable | $71K-52.8% | $150K+55.6% | $96K | — | — |
| Property and equipment [Note 13] | $10K-38.3% | $16K-27.7% | $22K-21.7% | $27K | — |
| Operating right of use assets [Note 12] | $812K-33.5% | $1.2M-23.0% | $1.6M+27.7% | $1.2M+1779.5% | $66K |
| TOTAL ASSETS | $5.6M-5.1% | $5.9M-8.7% | $6.5M-61.0% | $16.7M+275.8% | $4.4M |
| Accounts payable and accrued liabilities [Note 4] | $7.7M-20.3% | $9.6M+90.6% | $5.0M+94.3% | $2.6M+3.0% | $2.5M |
| Convertible promissory notes and short term loans [Note 5] | $9.6M+4.1% | $9.2M+93.5% | $4.8M+210.0% | $1.5M-64.0% | $4.3M |
| Term loan, current | $2.4M+0.0% | $2.4M | — | — | — |
| Derivative liabilities [Note 8] | $1.5M+3.0% | $1.4M+89.1% | $759K+115.4% | $352K-14.1% | $410K |
| Operating lease obligations, current [Note 10] | $531K+16.2% | $457K+36.3% | $336K+59.6% | $210K+261.0% | $58K |
| Total current liabilities | $20.6M-9.1% | $22.7M+103.4% | $11.2M+129.3% | $4.9M-53.6% | $10.5M |
| Federally guaranteed loans [Note 7] | $871K+0.0% | $871K+0.0% | $871K+0.0% | $871K+134.8% | $371K |
| Term loan [Note 6] | $12.3M+22.9% | $10.0M-18.0% | $12.2M+4.9% | $11.6M | — |
| Operating lease obligations | $398K-57.2% | $929K-33.0% | $1.4M+23.8% | $1.1M | — |
| TOTAL LIABILITIES | $35.7M-0.7% | $35.9M+36.3% | $26.4M+40.0% | $18.8M+67.0% | $11.3M |
| Common stock, $0.001 par value, 125,000,000 authorized as at March 31, 2025 and March 31, 2024, respectively. Issued and outstanding common shares: 26,081,295 and 9,353,768 as at March 31, 2025 and March 31, 2024, respectively, and exchangeable shares of 160,672 outstanding as at March 31, 2025 and March 31, 2024, respectively [Note 9] | $26K+175.8% | $10K+8.7% | $9K-82.9% | $51K+31.4% | $39K |
| Shares to be issued (581,599 and 324,276 shares of common stock as at March 31, 2025 and March 31, 2024, respectively) [Note 9] | $284K+5.6% | $269K+976.3% | $25K-75.6% | $102K-63.6% | $281K |
| Additional paid-in-capital | $107.0M+11.8% | $95.7M+3.1% | $92.8M+1.5% | $91.5M+62.5% | $56.3M |
| Accumulated other comprehensive gain (loss) | $146K+350.3% | $32K+121.2% | -$153K+80.1% | -$769K-21.2% | -$634K |
| Accumulated deficit | -$139.4M-9.4% | -$127.5M-13.3% | -$112.6M-21.0% | -$93.0M-48.1% | -$62.8M |
| Total stockholders’ deficiency | -$32.0M-1.7% | -$31.5M-58.6% | -$19.8M-825.3% | -$2.1M+68.6% | -$6.8M |
| TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ DEFICIENCY | $5.6M-5.1% | $5.9M-8.7% | $6.5M-61.0% | $16.7M+275.8% | $4.4M |
| Series B Convertible Redeemable Preferred Stock [Member] | |||||
| Series B Convertible Redeemable preferred stock, 0.001 par value, 600 shares authorized as of March 31, 2025 and March 31, 2024, respectively, 385and 265 shares issued and outstanding as of March 31, 2025 and March 31, 2024, respectively [Note 9] | $2.0M+34.3% | $1.5M | — | — | — |
| Preferred Stock [Member] | |||||
| Preferred stock, value | $6+500.0% | $1-83.3% | $6-14.3% | $7-12.5% | $8 |
| Series A Preferred Stock [Member] | |||||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.